[Federal Register Volume 65, Number 49 (Monday, March 13, 2000)]
[Notices]
[Page 13289]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-6014]


 ========================================================================
 Notices
                                                 Federal Register
 ________________________________________________________________________
 
 This section of the FEDERAL REGISTER contains documents other than rules 
 or proposed rules that are applicable to the public. Notices of hearings 
 and investigations, committee meetings, agency decisions and rulings, 
 delegations of authority, filing of petitions and applications and agency 
 statements of organization and functions are examples of documents 
 appearing in this section.
 
 ========================================================================
 

  Federal Register / Vol. 65, No. 49 / Monday, March 13, 2000 / 
Notices  

[[Page 13289]]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Consensus Development Conference on Osteoporosis Prevention, 
Diagnosis, and Therapy

    Notice is hereby given of the National Institutes of Health (NIH) 
Consensus Development Conference on ``Osteoporosis Prevention, 
Diagnosis, and Therapy,'' which will be held March 27-29, 2000, in the 
NIH's Natcher Conference Center, 9000 Rockville Pike, Bethesda, 
Maryland 20892. The conference begins at 8:00 am on March 27, at 8:30 
am on March 28, and at 9:00 am on March 29 and is open to the public.
    The most common bone disease in the United States, osteoporosis 
affects 10 million people in this country, with 18 million more at 
increased risk due to low bone mass. Osteoporosis is characterized by 
low bone mass and structural deterioration of bone tissue, leading to 
bone fragility and an increased susceptibility to fractures--
particularly of the hip, spine, and wrist. Women are four times more 
likely than men to develop osteoporosis.
    The purpose of the 2\1/2\-day conference is to clarify, for health 
care providers and the public, the factors associated with prevention 
and better diagnosis and treatment of osteoporosis. After 1\1/2\ days 
of presentations and audience discussion of the latest osteoporosis 
research, an independent, non-Federal consensus development panel will 
weigh the scientific evidence and draft a statement addressing the 
following key questions:
    What is osteoporosis and what are its consequences?
    How do risks vary among different segments of the population?
    What factors are involved in building and maintaining skeletal 
health throughout life?
    What is the optimal evaluation and treatment of osteoporosis and 
fractures?
    What are the directions for future research?
    On the final day of the conference, the panel's draft statement 
will be read in public, at which time members of the public are invited 
to offer comments on the draft.
    The primary organizers of this meeting are the National Institute 
of Arthritis and Musculoskeletal and Skin Diseases and the NIH Office 
of Medical Applications of Research. Other supporters include the 
National Institute on Aging; the National Institute of Diabetes and 
Digestive and Kidney Diseases; the National Institute of Dental and 
Craniofacial Research; the National Institute of Child Health and Human 
Development; the National Institute of Nursing Research; the National 
Institute of Environmental Health Sciences; the National Heart, Lung, 
and Blood Institute; the NIH Office of Research on Women's Health; and 
the Agency for Healthcare Research and Quality (formerly the Agency for 
Health Care Policy and Research).
    This is the 111th Consensus Development Conference held by the NIH 
in the 23-year history of the Consensus Development Program. Advance 
information about the conference and conference registration materials 
may be obtained from Prospect Associates of Silver Spring, Maryland, by 
calling (301) 592-3320 or by sending email to 
[email protected]. Prospect Associates' address is 10720 
Columbia Pike, Suite 500, Silver Spring, Maryland 20901-4437. A 
conference agenda and registration information is also available on the 
NIH Consensus Program Web site at http://consensus.nih.gov.

    Dated: March 2, 2000.
Ruth L. Kirschstein,
Acting Director, NIH.
[FR Doc. 00-6014 Filed 3-10-00; 8:45 am]
BILLING CODE 4140-01-P